Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Poitiers University Hospital

Status

Enrolling

Conditions

Artificial Intelligence Algorithms

Clinical

Radiological

Development of the Virtual Biopsy

Tumor Grade

Treatments

Diagnostic Test: Diagnostic test

Study type

Interventional

Funder types

Other

Identifiers

NCT04313140

2019-A02531-56

Details and patient eligibility

About

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age≥ 18 years,
Patient with suspected glioma with prior imaging
Subject free, with legal protection guardianship or curatorship;
Enrollment in the French Social Security system;
Informed consent signed by the patient

Exclusion criteria

Any contraindication to an MRI examination
Legal protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons residing in a health or social establishment, adults under legal protection and finally patients in emergency situations
Pregnant or lactating women, women of childbearing age who do not have effective contraception